Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • HELLO- A method based on DNN architecture

Inborn errors of immunity & corresponding protein interactions

Proteomic study of Alzheimer’s Disease

HELLO- A method based on DNN architecture
  • BiotechToday
  • World

HELLO- A method based on DNN architecture

bioxone August 18, 2021August 18, 2021

Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati

Variant calling is the process by which we can identify variants in the sequence data provided. Variant calling has a major application in modern bioinformatics. It helps in discovering the underlying traits of Mendelian diseases, in understanding the individual’s susceptibility to cancer, and also to study genetic diversity to help strategize various crop-breeding methods. It also helps in understanding small insertions, substitutions, and deletions (indels) that account for most of the mutations in the human genome which are of great interest in most of the studies. Probing the human genome can be done at higher resolution by using advanced sequencing technologies. The sequencing reads from next-generation platforms (NGS) for example Illumina is of few hundred bases long and highly accurate.

Variant calling methods

Traditionally, the variant calling methods have used probabilistic models of sequencing errors and sequencing read alignment in order to determine the likelihoods of variation at genomic loci from sequencing data. For Eg: the pair-Hidden Markov model (HMM) is used to determine alignment probabilities of reads to different candidate haplotypes at a site thus leading to the determination of the best haplotypes at the site. Another model known as Deep Variant uses a Deep Neural Network (DNN) that makes predictions for candidate alternative alleles and pairs of candidate alternative alleles at a site. The predictions made by DNN are then converted into variant calls by using additional algorithms that filter, sort and rank the different alleles at a time. Another learning model is Clairvoyant, which is a small variant caller that runs rapidly for SNVs and indels of length up to 4 bp. 

HELLO (Hybrid and stand-alone Estimation of smaLL genOmic variants) method

A DNN (deep neural network) architecture is built that recognizes the reads and alleles as they are the elements of the problem, and then introduces specific constructs that encode the relationship of reads to alleles, as well as the relationship of one allele to another allele. Thus, this method is built for small variant calling and accounts for the nature and structure of genome sequencing data and tailors the DNN model to the problem at hand. In this method, DNN predictions used for each allele at the site can be combined to produce the variant call result by using log-likelihood maximization instead of resorting to complex algorithms or a second machine learning method. This method might also allow the entire framework to be extended to the polyploidy cases also with no changes in the underlying DNN. The HELLO method was compared to DeepVariant and Genome Analysis Toolkit (GATK) using sample datasets. HELLO, the model was up to 14x smaller in terms of parameter count as compared to Deepvariant but performed similarly to or better than Deepvariant in different settings. After performing the experiments, it was observed that-

  • For PacBio, the HELLO method outperformed Deepvariant and GATK in all cases.
  • For hybrid variant calling, the HELLO method outperformed DeepVariant in all cases except SNV cases. It was observed that DeepVariant makes approximately 5% fewer errors in this case.
  • For Illumina variant calling, HELLO outperformed as compared to DeepVariant and GATK in all cases except indel, DeepVariant made approx. 3% fewer cases.

Conclusion: A DNN architecture model considers that reads are the fundamental units of sequencing data, more reads supporting the same candidate allele reinforce the confidence in the allele and the confidence in the allele should be evaluated in relation to other candidates alleles in a simple manner. Thus such a DNN architecture should be built that works for the problem by encoding assumptions that can be made regarding sequencing data and variant calling directly into the structure of the DNN. 

Also read: Inborn errors of immunity & corresponding protein interactions

Reference: Ramachandran, A., Lumetta, S. S., Klee, E. W., & Chen, D. (2021). HELLO: Improved neural network architectures and methodologies for small variant calling. BMC Bioinformatics, 22(1), 404. https://doi.org/10.1186/s12859-021-04311-4

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged Allele Deep Neural Network DeepVariant HELLO human genome indels sequence data Variant calling

One thought on “HELLO- A method based on DNN architecture”

  1. Pingback: Sea corals – A new way to combat heat stress - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Proteomic study of Alzheimer’s Disease

bioxone August 19, 2021

Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati Alzheimer’s disease (AD) is a progressive neurodegenerative disease and is also age-associated. Approximately 5.8 million people are affected by this disease in the United States. Typically the onset of AD mostly occurs after the age of 65. The primary clinical manifestations of the disease cover profound cognitive […]

Alzheimer’s

Related Post

  • BiotechToday
  • World

Cytomegalovirus retinitis in mice with murine acquired immunodeficiency syndrome

bioxone November 12, 2020November 12, 2020

Parnad Basu, Amity University Kolkata CMV retinitis (cytomegalovirus retinitis) is an inflammation of the retina of the eye which can lead to blindness. CMV retinitis is caused by human cytomegalovirus (HCMV). CMV retinitis is mainly an AIDS (acquired immunodeficiency syndrome) related opportunistic disease, some cases also report it during bone marrow transfer. Scientists studying AIDS-related […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

New metabolic methods for the treatment of Glaucoma

bioxone December 19, 2020December 18, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA The incurable eye disease Glaucoma leads to partial or total vision loss in approximately 80 million people. Therefore, it was extremely crucial to find a way around this complicated disease; the relation between metabolic disturbance in the nerve cells in the retina and high intraocular pressure. Moreover, in animal models, […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India

INDIA’S CALL FOR PFIZER AGAINST COVID 19

bioxone December 8, 2020December 8, 2020

SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA The authorization for Pfizer’s vaccine candidate came in just 10 months since it initiated developing it, which is the fastest in the history of vaccines. Pfizer has become the main organization to seek emergency use endorsement of its immunization applicant in India after getting clearance in the UK and Bahrain. […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy